Survival of castration-resistant prostate cancer patients treated with dendritic-tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56bright CD16- natural killer cells.

Helena H ChowdhurySimon HawlinaMateja GabrijelSaša Trkov BobnarMarko KreftGordan LenartMarko CukjatiAndreja Nataša KopitarNataša KejžarAlojz IhanLuka LežaičMarko GrmekAndrej KmetecMatjaž JerasRobert Zorec

Published in: Clinical and translational medicine (2022)

Keyphrases

natural killer cells
peripheral blood
single cell
cell therapy
stem cells
free survival